V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240007648 | 240004731 | null | 118.8 | Palliative (P) | 2017-11-09 | 2017-11-15 | Chlorambucil | N | N | 240034180 | CHLORAMBUCIL |
| 240007649 | 240004732 | 1.66 | 61.2 | null | 2017-06-09 | 2017-06-09 | Chlorambucil | 02 | N | 240034187 | CHLORAMBUCIL |
| 240007650 | 240004733 | 1.75 | 104.3 | Curative (C) | 2017-07-21 | 2017-08-01 | INTERLACE TRIAL | 01 | N | 240034188 | INTERLACE TRIAL |
| 240007651 | 240004734 | 1.73 | 100.4 | Disease modification (D) | 2017-04-03 | 2017-04-03 | R Chlorambucil | N | N | 240034190 | CHLORAMBUCIL + RITUXIMAB |
| 240007652 | 240004735 | 1.65 | 78 | Neo-adjuvant (N) | 2016-07-01 | 2016-07-13 | INTERLACE TRIAL | N | N | 240034192 | INTERLACE TRIAL |
| 240007653 | 240004736 | null | 81.8 | Adjuvant (A) | 2016-06-07 | 2016-06-21 | null | 02 | N | 240034202 | NOT MATCHED |
| 240007654 | 240004737 | 1.61 | 80.2 | Palliative (P) | 2017-03-11 | 2017-03-13 | Hydroxycarbamide | 2 | N | 240034204 | HYDROXYCARBAMIDE |
| 240007655 | 240004738 | 1.49 | null | Curative (C) | 2016-09-11 | 2016-09-19 | Carboplatin + Etoposide iv&po | null | null | 240034210 | CARBOPLATIN + ETOPOSIDE |
| 240007656 | 240004739 | 1.59 | 50.5 | Palliative (P) | 2013-08-18 | 2013-09-02 | Bevacizumab+Carbo+Pacliaxel | N | N | 240034211 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007657 | 240004740 | 1.63 | 54.4 | null | null | 2014-05-13 | Chlorambucil | N | N | 240034212 | CHLORAMBUCIL |
| 240007658 | 240004741 | 1.66 | 49.3 | Curative (C) | 2014-06-06 | 2014-06-21 | INTERLACE TRIAL | N | N | 240034213 | INTERLACE TRIAL |
| 240007659 | 240010635 | null | null | null | null | 2017-08-03 | null | N | N | 240034220 | NOT MATCHED |
| 240007660 | 240010635 | 1.6 | 75 | Palliative (P) | 2018-04-05 | 2018-04-05 | R Chlorambucil | N | Y | 240034220 | CHLORAMBUCIL + RITUXIMAB |
| 240007661 | 240010635 | null | null | Palliative (P) | 2016-10-31 | 2016-11-09 | Chlorambucil | 02 | N | 240034220 | CHLORAMBUCIL |
| 240007662 | 240015646 | 1.67 | 56 | Disease modification (D) | 2014-04-13 | 2015-06-10 | Hydroxycarbamide | N | N | 240034242 | HYDROXYCARBAMIDE |
| 240007663 | 240004742 | 1.64 | null | Palliative (P) | 2016-12-08 | 2016-12-10 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240034243 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007664 | 240004742 | 1.61 | 81.9 | Palliative (P) | 2013-06-12 | 2013-06-19 | Chlorambucil + Pred + Rituximab | null | null | 240034243 | CHLORAMBUCIL + RITUXIMAB |
| 240007665 | 240004742 | 1.56 | 66.4 | Palliative (P) | 2015-05-07 | 2015-05-14 | DA 3 + 10 | null | N | 240034243 | DA |
| 240007666 | 240004743 | 1.7 | null | Palliative (P) | 2018-06-10 | 2018-06-15 | Bevacizumab+Carbo+Pacliaxel | N | N | 240034254 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007667 | 240004744 | 1.68 | 100 | Palliative (P) | null | 2017-07-04 | Carboplatin AUC 2 - 5 | 02 | N | 240034257 | CARBOPLATIN |
| 240007668 | 240004744 | 175 | null | Palliative (P) | 2016-06-18 | 2016-06-22 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 240034257 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007669 | 240004745 | null | null | null | null | 2015-09-28 | CARBOPLATIN | N | N | 240034263 | CARBOPLATIN |
| 240007670 | 240004745 | 1.73 | 72 | Adjuvant (A) | 2017-08-05 | 2017-08-06 | Chlorambucil | N | N | 240034263 | CHLORAMBUCIL |
| 240007671 | 240004746 | 166 | 99.6 | Curative (C) | 2015-02-13 | 2015-02-28 | SMILE | 01 | N | 240034268 | TRIAL |
| 240007672 | 240004747 | 0 | 63 | Palliative (P) | 2018-08-23 | 2018-08-23 | Hydroxycarbamide | Y | Y | 240034270 | HYDROXYCARBAMIDE |
| 240007673 | 240004748 | 1.63 | 51 | Curative (C) | 2016-08-02 | 2016-08-24 | R Chlorambucil | N | N | 240034274 | CHLORAMBUCIL + RITUXIMAB |
| 240007674 | 240004748 | 1.7 | 50.4 | Curative (C) | 2016-09-22 | 2016-09-23 | Trial Unspecified | N | N | 240034274 | TRIAL |
| 240007675 | 240004749 | 1.62 | 99.3 | Disease modification (D) | 2013-12-17 | 2013-12-18 | Chlorambucil | N | N | 240034283 | CHLORAMBUCIL |
| 240007676 | 240010640 | 1.6 | 89.6 | Not known (9) | 2013-10-28 | 2013-10-28 | CHLORAMBUCIL + RITUXIMAB | N | N | 240034285 | CHLORAMBUCIL + RITUXIMAB |
| 240007677 | 240010640 | 1.61 | 74 | Palliative (P) | 2018-06-06 | 2018-07-03 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240034285 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007678 | 240010640 | null | null | Palliative (P) | 2013-02-27 | 2013-04-08 | Bevacizumab+Carbo+Pacliaxel | null | null | 240034285 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007679 | 240015647 | 1.75 | 70.75 | Curative (C) | 2013-06-11 | 2013-06-11 | INTERLACE TRIAL | N | N | 240034291 | INTERLACE TRIAL |
| 240007680 | 240004750 | 1.73 | 110.9 | Disease modification (D) | null | 2018-03-30 | Chlorambucil | null | N | 240034294 | CHLORAMBUCIL |
| 240007681 | 240004750 | 1.64 | 80.1 | Disease modification (D) | 2013-10-24 | 2013-11-01 | Chlorambucil | 2 | N | 240034294 | CHLORAMBUCIL |
| 240007682 | 240004751 | 1.55 | null | Curative (C) | 2014-11-17 | 2014-11-17 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine + RITUXIMAB | N | N | 240034299 | NOT MATCHED |
| 240007683 | 240004751 | 1.72 | 70.5 | Not known (9) | 2015-09-27 | 2015-10-13 | CHLORAMBUCIL + RITUXIMAB | 2 | N | 240034299 | CHLORAMBUCIL + RITUXIMAB |
| 240007684 | 240004752 | 1.56 | null | Palliative (P) | 2017-09-15 | 2017-09-18 | Hydroxycarbamide | N | N | 240034311 | HYDROXYCARBAMIDE |
| 240007685 | 240004753 | 1.75 | 99.6 | Curative (C) | 2015-10-28 | 2015-11-04 | CHLORAMBUCIL + RITUXIMAB | Y | Y | 240034312 | CHLORAMBUCIL + RITUXIMAB |
| 240007686 | 240004753 | 1.55 | 61.9 | Curative (C) | 2016-10-06 | 2016-10-06 | R Chlorambucil | N | N | 240034312 | CHLORAMBUCIL + RITUXIMAB |
| 240007687 | 240004753 | 1.77 | 69.7 | Palliative (P) | 2017-10-11 | 2017-10-15 | Hydroxycarbamide | N | N | 240034312 | HYDROXYCARBAMIDE |
| 240007688 | 240004753 | 1.6 | 70 | Curative (C) | null | 2016-09-29 | Trial Unspecified | N | N | 240034312 | TRIAL |
| 240007689 | 240004753 | 1.72 | 69 | Palliative (P) | null | 2015-04-09 | Bevacizumab+Carbo+Pacliaxel | N | N | 240034312 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007690 | 240004754 | 1.68 | 74 | Curative (C) | 2016-08-04 | 2016-08-07 | CYTARABINE + DAUNORUBICIN | 2 | N | 240034324 | DA |
| 240007691 | 240004754 | 1.54 | 0 | Curative (C) | null | 2015-01-06 | DA 3 + 10 | N | N | 240034324 | DA |
| 240007692 | 240004755 | 1.74 | 69 | Curative (C) | 2016-09-01 | 2016-09-03 | Chlorambucil | null | null | 240034329 | CHLORAMBUCIL |
| 240007693 | 240004756 | 1.6 | 58.7 | Disease modification (D) | 2013-06-20 | 2013-06-21 | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB | Y | N | 240034332 | NOT MATCHED |
| 240007694 | 240004757 | 1.74 | 55.9 | Palliative (P) | null | 2015-10-17 | Carboplatin AUC 2 - 5 | N | N | 240034338 | CARBOPLATIN |
| 240007695 | 240004757 | null | 93 | Palliative (P) | 2016-03-07 | 2016-03-13 | Chlorambucil | N | N | 240034338 | CHLORAMBUCIL |
| 240007696 | 240004758 | null | null | Curative (C) | 2016-11-07 | 2016-11-15 | INTERLACE TRIAL | Y | null | 240034344 | INTERLACE TRIAL |
| 240007697 | 240010646 | 1.56 | 77.1 | Palliative (P) | 2013-07-05 | 2013-08-08 | CARBOPLATIN | N | N | 240034346 | CARBOPLATIN |